Navigation Links
Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study

Rolf Engstad, tel.: 95 94 15 42 CFO Finn Samuelsen, tel.: 95 14 87 51

About SBG

SBG (soluble beta-1,3/1,6-glucan) is Biotec Pharmacon's patented pharmaceutical compound. SBG binds to certain types of immune cells and initiates mechanisms that enhance the ability of the immune system to attack and destroy cancer cells, repair wounds, and fight infections. Immunotherapy of cancer is one of the priority therapeutic areas for Biotec Pharmacon. In addition to the study at Memorial Sloan-Kettering Cancer Center i New York, the company is also about to conduct two studies at Ullevaal University Hospital and Rikshospitalet-Radiumhospitalet in Oslo. The other therapeutic area covered by Biotec Pharmacon is treatment of wounds which include chronic diabetic ulcers and oral mucositis in cancer patients. Biotec Pharmacon has recently announced that the company enters clinical phase III within these indications.

About Biotec Pharmacon

The biopharmaceutical company Biotec Pharmacon was founded in 1990 and develops pharmaceutical products for treatment of immune related diseases. The company has developed the bioactive compound SBG, which initiates mechanisms that strengthen the ability of the immune system to destroy cancer cells, repair wounds and fight infections. In addition the company manufactures and markets non-pharmaceutical health- and diagnostics products. Biotec Pharmacon maintains comprehensive collaborations with renowned institutions such as for example Memorial Sloan-Kettering Cancer Center in New York. Biotec Pharmacon today has 56 employees and offices in Tromsø, Oslo and Long Beach, USA. Further information can be found on www.biotec.no.


'"/>




Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
6. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
7. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
8. Prana Biotechnology Presents New Key Findings on PBT2
9. Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S. Phase I REOLYSIN Trial
10. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
Post Your Comments:
(Date:8/19/2008)...ewswire-FirstCall/ --,Pharmaceutical company Pharm... the Phase 3 clinical trial evaluating the long te...tasis has concluded with no serious,adverse events...atment., A total of 123 subjects started treatmen...ects completed the full 12 months of the trial. Of...
(Date:8/19/2008)...- Particle Sciences Inc. has,expanded its Combinat...d,pilot production capabilities with the installat...ing line. The core of the pilot line,comprising a...20T injection,molder, enables the production of hi...ition gives Particle Sciences the ability to go fr...
(Date:8/19/2008)...used to identify molecular,signature of motor neur...-USNewswire/ -- ALS Therapy,Development Institute ...LS,biomarker effort using blood samples collected ...ps. These ongoing projects are part of the,Institu...ression of genes,and proteins, at the onset of, an...
(Date:8/19/2008)...ll/ -- Vical Incorporated,(Nasdaq: VICL ) today a...ska,Institute, a leading European medical universi...se Control (SMI), a governmental expert agency, to...iojector(R) 2000,needle-free injection system (Bio...multivalent preventive DNA vaccine against HIV., ...
Breaking Medicine Technology:12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 212 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis 3Particle Sciences Expands Its Combination Product Capabilities 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Many States Still Fall Short in Emergency Preparedness 3A Report 8484 1Many States Still Fall Short in Emergency Preparedness 3A Report 8484 2Many States Still Fall Short in Emergency Preparedness 3A Report 8484 3Many States Still Fall Short in Emergency Preparedness 3A Report 8484 4Rhode Island Hospital to study driving ability of cognitively impaired elders 8483 1NightHawk Radiology Holdings Inc to Speak at Annual JPMorgan Healthcare Conference on January 10 2008 8481 1NightHawk Radiology Holdings Inc to Speak at Annual JPMorgan Healthcare Conference on January 10 2008 8481 2SecureWorks Designated as a Qualified Security Assessor for PCI Audits 8478 1SecureWorks Designated as a Qualified Security Assessor for PCI Audits 8478 2
...ce shortly, CARMIEL, Israel, April 18, 2007 /PRNew.... today announced that it has received,written not...ation,(FDA) that it may initiate a Phase III clini... candidate, prGCD, a proprietary plant,cell expres...GCD),for the treatment of Gaucher Disease, a lyso...
... out of ten patients taking,once-daily Lialda rema...TON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- ...nsion study (303),presented at the British Society...tland in March 2007 showed Shire plc,s,Lialda(mesa...atients. Today, secondary endpoints of study 303 w...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...oped by scientists to enable the easy detection of...are two factors which are called for// where cance...archers led by Professor Calum McNeil are engaged ...er markers - proteins or other molecules produced ...
... statement, highlighting the unwillingness of Chin... bird flu outbreaks.// This was stated following a...ath, by Beijing. The deadly avian bird flu virus ...41-year-old factory worker, from the Southeastern ...
...ence of H5N1 bird flu strain in the poultry sample... the deadly bird flu strain // in six villages Mod... of Romania. Early this month five new cases of ... in Buzau County. Bird flu was first detected in D...
... at the UT Southwestern Medical Center has found t... urinary bladder if a woman is coached during labo... presence of a coach does not seem to provide any ...shortening labor. The study is the first of its k...
Other Medicine News:Health News:Coaching In Labor Could Increase Bladder Problems 2
...e (GH) is a monomeric protein produced and stored ...H is released from the pituitary into the bloodstr...trol of hypothalamic somatostatin (SS) and GH-rele...of GH release appears to be regulated by somatosta...
...he most potent glucocorticoid produced by the huma...d with high affinity to corticosteroid-binding glo...lbumin. Cortisol acts on specific intracellular re...ms, including immune function, glucose counter-reg...
...growth factor I (IGF-I or somatomedin C) is a 7.6 ...ts as a potent mitogen of cellular proliferation, ...urface receptors. In the circulation, IGF-I is bou...to regulate the actions of IGF-I by modulating the...
...growth factor I (IGF-I or somatomedin C) is a 7.6 ...ts as a potent mitogen of cellular proliferation, ...urface receptors. In the circulation, IGF-I is bou...to regulate the actions of IGF-I by modulating the...
Medicine Products: